| ZNF518A | zinc finger protein 518A | 10q23.33 | 0.359 | 0.49 | 0
|
| ERBB3 | erb-b2 receptor tyrosine kinase 3 | 12q13 | 0.359 | 0.467 | 0
|
| CD14 | CD14 molecule | 5q31.3 | 0.351 | -0.436 | 0
|
| PHF8 | PHD finger protein 8 | Xp11.22 | 0.344 | 0.414 | 0
|
| PCP4L1 | Purkinje cell protein 4 like 1 | 1q23.3 | 0.336 | 0.475 | 0
|
| GLIPR2 | GLI pathogenesis-related 2 | 9p13.3 | 0.334 | -0.414 | 0
|
| SC5D | sterol-C5-desaturase | 11q23.3 | 0.331 | 0.491 | 0
|
| KSR2 | kinase suppressor of ras 2 | 12q24.22-q24.23 | 0.327 | 0.495 | 0
|
| BCAS1 | breast carcinoma amplified sequence 1 | 20q13.2 | 0.326 | 0.491 | 0
|
| MFI2 | antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 | 3q28-q29 | 0.321 | -0.464 | 0
|
| MT2A | metallothionein 2A | 16q13 | 0.32 | -0.476 | 0
|
| CACNA1D | calcium channel, voltage-dependent, L type, alpha 1D subunit | 3p14.3 | 0.32 | 0.502 | 0
|
| PPP1R18 | protein phosphatase 1, regulatory subunit 18 | 6p21.3 | 0.319 | -0.501 | 0
|
| PLEKHH1 | pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 | 14q24.1 | 0.318 | 0.474 | 0
|
| PDCD1LG2 | programmed cell death 1 ligand 2 | 9p24.2 | 0.318 | -0.454 | 0
|
| UBN2 | ubinuclein 2 | 7q34 | 0.317 | 0.45 | 0
|
| GPD1L | glycerol-3-phosphate dehydrogenase 1-like | 3p22.3 | 0.317 | 0.44 | 0
|
| CAPN14 | calpain 14 | 2p23.1-p21 | 0.313 | 0.431 | 0
|
| IGF2BP2 | insulin-like growth factor 2 mRNA binding protein 2 | 3q27.2 | 0.312 | -0.422 | 0
|
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 19q13.1 | 0.311 | 0.54 | 0
|
| SLC5A7 | solute carrier family 5 (sodium/choline cotransporter), member 7 | 2q12 | 0.311 | 0.442 | 0
|
| ZBTB7C | zinc finger and BTB domain containing 7C | 18q21.1 | 0.309 | 0.379 | 2.9e-16
|
| ACADSB | acyl-CoA dehydrogenase, short/branched chain | 10q26.13 | 0.309 | 0.522 | 0
|
| RERE | arginine-glutamic acid dipeptide (RE) repeats | 1p36.23 | 0.308 | 0.333 | 2.23e-12
|
| PLA2G4F | phospholipase A2, group IVF | 15q15.1 | 0.308 | 0.437 | 0
|
| GCNT4 | glucosaminyl (N-acetyl) transferase 4, core 2 | 5q12 | 0.305 | 0.456 | 0
|
| TAP2 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) | 6p21.3 | 0.303 | -0.397 | 0
|
| BNIPL | BCL2/adenovirus E1B 19kD interacting protein like | 1q21.2 | 0.299 | 0.474 | 0
|
| CMYA5 | cardiomyopathy associated 5 | 5q14.1 | 0.298 | 0.411 | 0
|
| PANX1 | pannexin 1 | 11q14-q21 | 0.297 | -0.422 | 0
|
| METTL7A | methyltransferase like 7A | 12q13.12 | 0.295 | 0.473 | 0
|
| TMSB10 | thymosin beta 10 | 2p11.2 | 0.294 | -0.399 | 0
|
| EVX1 | even-skipped homeobox 1 | 7p15.2 | 0.293 | 0.449 | 0
|
| FCRLB | Fc receptor-like B | 1q23.3 | 0.292 | 0.427 | 0
|
| ACP2 | acid phosphatase 2, lysosomal | 11p11.2 | 0.292 | -0.447 | 0
|
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 5q23.1 | 0.292 | 0.445 | 0
|
| VAV3 | vav 3 guanine nucleotide exchange factor | 1p13.3 | 0.291 | 0.442 | 0
|
| SASH1 | SAM and SH3 domain containing 1 | 6q24.3 | 0.289 | 0.414 | 0
|
| AOC2 | amine oxidase, copper containing 2 (retina-specific) | 17q21 | 0.289 | 0.464 | 0
|
| LDB1 | LIM domain binding 1 | 10q24-q25 | 0.289 | 0.388 | 0
|
| FSTL4 | follistatin-like 4 | 5q31.1 | 0.287 | 0.399 | 0
|
| SYNGR1 | synaptogyrin 1 | 22q13 | 0.287 | 0.505 | 0
|
| GRHPR | glyoxylate reductase/hydroxypyruvate reductase | 9q12 | 0.286 | -0.461 | 0
|
| FGFR3 | fibroblast growth factor receptor 3 | 4p16.3 | 0.281 | 0.43 | 0
|
| CPAMD8 | C3 and PZP-like, alpha-2-macroglobulin domain containing 8 | 19p13.12 | 0.28 | 0.469 | 0
|
| FADS6 | fatty acid desaturase 6 | 17q25.1 | 0.279 | 0.507 | 0
|
| C10orf105 | chromosome 10 open reading frame 105 | 10q22.1 | 0.276 | 0.377 | 6.04e-16
|
| ADAD2 | adenosine deaminase domain containing 2 | 16q24.1 | 0.276 | 0.454 | 0
|
| FBLN7 | fibulin 7 | 2q13 | 0.274 | -0.343 | 4.44e-13
|
| PLGRKT | plasminogen receptor, C-terminal lysine transmembrane protein | 9p24.1 | 0.272 | -0.453 | 0
|
| PSIP1 | PC4 and SFRS1 interacting protein 1 | 9p22.2 | 0.272 | -0.352 | 9.53e-14
|
| LIMD1 | LIM domains containing 1 | 3p21.31 | 0.271 | 0.34 | 7.08e-13
|
| LPIN3 | lipin 3 | 20q11.2-q12 | 0.269 | 0.342 | 4.75e-13
|
| MSMB | microseminoprotein, beta- | 10q11.2 | 0.267 | 0.425 | 0
|
| POU3F1 | POU class 3 homeobox 1 | 1p34.3 | 0.265 | 0.434 | 0
|
| CACNA1I | calcium channel, voltage-dependent, T type, alpha 1I subunit | 22q13.1 | 0.265 | 0.45 | 0
|
| CALM2 | calmodulin 2 (phosphorylase kinase, delta) | 2p21.3-p21.1 | 0.263 | -0.424 | 0
|
| HLA-H | major histocompatibility complex, class I, H (pseudogene) | 6p21.3 | 0.262 | -0.347 | 2.02e-13
|
| ANXA3 | annexin A3 | 4q21.21 | 0.262 | -0.317 | 2.58e-11
|
| SLC2A10 | solute carrier family 2 (facilitated glucose transporter), member 10 | 20q13.12 | 0.261 | 0.462 | 0
|
| CKMT1B | creatine kinase, mitochondrial 1B | 15q15 | 0.256 | 0.229 | 1.77e-06
|
| DUOX1 | dual oxidase 1 | 15q21 | 0.256 | 0.371 | 2.51e-15
|
| ADRB1 | adrenoceptor beta 1 | 10q25.3 | 0.255 | 0.499 | 0
|
| MTSS1L | metastasis suppressor 1-like | 16q22.1 | 0.255 | 0.379 | 3.24e-16
|
| CDKN2A | cyclin-dependent kinase inhibitor 2A | 9p21 | 0.252 | -0.331 | 3.22e-12
|
| STAC | SH3 and cysteine rich domain | 3p22.3 | 0.252 | -0.3 | 2.98e-10
|
| WNT5B | wingless-type MMTV integration site family, member 5B | 12p13.3 | 0.247 | -0.277 | 6.63e-09
|
| SLC52A1 | solute carrier family 52 (riboflavin transporter), member 1 | 17p13.3 | 0.243 | 0.356 | 4.14e-14
|
| TMEM14B | transmembrane protein 14B | 6p25.1-p23 | 0.243 | -0.313 | 4.83e-11
|
| HTR7P1 | 5-hydroxytryptamine (serotonin) receptor 7 pseudogene 1 | 12p13.1 | 0.241 | 0.308 | 9.95e-11
|
| TTC9 | tetratricopeptide repeat domain 9 | 14q24.2 | 0.241 | 0.195 | 5.33e-05
|
| IFNLR1 | interferon, lambda receptor 1 | 1p36.11 | 0.239 | 0.262 | 4.53e-08
|
| SRRM3 | serine/arginine repetitive matrix 3 | 7q11.23 | 0.239 | 0.335 | 1.58e-12
|
| SIPA1L2 | signal-induced proliferation-associated 1 like 2 | 1q42.2 | 0.237 | 0.221 | 4.11e-06
|
| WDR72 | WD repeat domain 72 | 15q21.3 | 0.234 | 0.239 | 6.38e-07
|
| MMRN2 | multimerin 2 | 10q23.31 | 0.234 | 0.367 | 5.34e-15
|
| ITIH6 | inter-alpha-trypsin inhibitor heavy chain family, member 6 | Xp11.22-p11.21 | 0.232 | 0.349 | 1.52e-13
|
| SPTAN1 | spectrin, alpha, non-erythrocytic 1 | 9q34.11 | 0.231 | -0.345 | 3.01e-13
|
| LRP12 | low density lipoprotein receptor-related protein 12 | 8q22.2 | 0.231 | -0.251 | 1.63e-07
|
| RRAGA | Ras-related GTP binding A | 9p21.3 | 0.231 | -0.304 | 1.76e-10
|
| SNX15 | sorting nexin 15 | 11q12 | 0.23 | -0.24 | 5.35e-07
|
| C11orf58 | chromosome 11 open reading frame 58 | 11p15.1 | 0.229 | -0.375 | 1.02e-15
|
| PLAC8 | placenta-specific 8 | 4q21.22 | 0.226 | -0.152 | 0.00162
|
| HOXC13 | homeobox C13 | 12q13.13 | 0.223 | 0.358 | 3.26e-14
|
| GPR158 | G protein-coupled receptor 158 | 10p12.31 | 0.222 | 0.074 | 0.125
|
| TEPP | testis, prostate and placenta expressed | 16q13 | 0.219 | 0.363 | 1.18e-14
|
| BAHD1 | bromo adjacent homology domain containing 1 | 15q14 | 0.219 | 0.35 | 1.2e-13
|
| RGS12 | regulator of G-protein signaling 12 | 4p16.3 | 0.218 | 0.218 | 5.96e-06
|
| RHOBTB2 | Rho-related BTB domain containing 2 | 8p21.2 | 0.217 | 0.255 | 9.74e-08
|
| ACO1 | aconitase 1, soluble | 9p21.1 | 0.214 | -0.297 | 4.47e-10
|
| SGCE | sarcoglycan, epsilon | 7q21.3 | 0.211 | -0.189 | 8.55e-05
|
| RNMT | RNA (guanine-7-) methyltransferase | 18p11.21 | 0.211 | 0.051 | 0.295
|
| C11orf80 | chromosome 11 open reading frame 80 | 11q13.2 | 0.21 | -0.025 | 0.6
|
| HPDL | 4-hydroxyphenylpyruvate dioxygenase-like | 1p34.1 | 0.21 | 0.131 | 0.00683
|
| SRR | serine racemase | 17p13 | 0.206 | -0.291 | 1.05e-09
|
| TNNI3 | troponin I type 3 (cardiac) | 19q13.4 | 0.206 | 0.153 | 0.00153
|
| HHLA3 | HERV-H LTR-associating 3 | 1p31.1 | 0.2 | -0.247 | 2.7e-07
|
| WBP4 | WW domain binding protein 4 | 13q13.3 | 0.189 | -0.007 | 0.89
|
| C1GALT1C1 | C1GALT1-specific chaperone 1 | Xq24 | 0.175 | -0.049 | 0.313
|